Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses

Moderate hyperthermia at temperatures between 40 and 44°C is a multifaceted therapeutic modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic agents, and, in combination with radiotherapy, enforces immunomodulation akin to “in situ tumor vaccination.” By sensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Datta, Niloy R., Kok, H. Petra, Crezee, Hans, Gaipl, Udo S., Bodis, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303270/
https://www.ncbi.nlm.nih.gov/pubmed/32596144
http://dx.doi.org/10.3389/fonc.2020.00819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303270/
https://www.ncbi.nlm.nih.gov/pubmed/32596144
http://dx.doi.org/10.3389/fonc.2020.00819

Ejemplares similares